Literature DB >> 21907957

Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic.

Laila Nurmohamed1, Myla E Moretti, Tal Schechter, Adrienne Einarson, Diana Johnson, Sharon V Lavigne, Aida Erebara, Gideon Koren, Yaron Finkelstein.   

Abstract

OBJECTIVE: The objective of this study was to report the outcomes of intrauterine pregnancies misdiagnosed as ectopic and exposed to methotrexate, a major teratogen. STUDY
DESIGN: We report the outcomes of all subjects who sought consultation after exposure to high-dose methotrexate to induce abortion in presumed ectopic pregnancies, which were later identified as viable intrauterine pregnancies by 3 North American Teratology Information Services between 2002 and 2010.
RESULTS: Eight women with normal, desired pregnancies were administered high-dose methotrexate in the first trimester because of presumed, misdiagnosed ectopic pregnancies. All pregnancies resulted in catastrophic outcomes. Two pregnancies resulted in severely malformed newborns with methotrexate embryopathy; 3 women miscarried shortly after exposure, and in 3 the erroneous diagnosis led the physicians to advise and perform surgical termination.
CONCLUSION: Erroneous diagnosis of intrauterine pregnancies as ectopic with subsequent first-trimester exposure to methotrexate may result in the birth of severely malformed babies or fetal demise.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907957     DOI: 10.1016/j.ajog.2011.07.002

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Methotrexate for management of twin pregnancy with complete hydatidiform mole and co-existing live fetus: A case report.

Authors:  Mhd Moamen Al Mouallem; Nazih Tawashi; Ieman AlAWAD; Fatima Alawad; Majd Hanna
Journal:  Int J Surg Case Rep       Date:  2022-06-18

Review 2.  Early pregnancy failure: beware of the pitfalls of modern management.

Authors:  Kurt T Barnhart
Journal:  Fertil Steril       Date:  2012-11       Impact factor: 7.329

3.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.

Authors:  Nadja Borisow; Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr; Kerstin Hellwig
Journal:  EPMA J       Date:  2012-06-22       Impact factor: 6.543

4.  Pregnancy of unknown location.

Authors:  Pedro Paulo Pereira; Fábio Roberto Cabar; Úrsula Trovato Gomez; Rossana Pulcineli Vieira Francisco
Journal:  Clinics (Sao Paulo)       Date:  2019-10-14       Impact factor: 2.365

Review 5.  Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literature.

Authors:  Marialuisa Framarino-dei-Malatesta; Giuseppina Perrone; Antonella Giancotti; Flavia Ventriglia; Martina Derme; Isabella Iannini; Valentina Tibaldi; Paola Galoppi; Paolo Sammartino; Gianluca Cascialli; Roberto Brunelli
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

Review 6.  Immunosuppressive drugs and fertility.

Authors:  Clara Leroy; Jean-Marc Rigot; Maryse Leroy; Christine Decanter; Kristell Le Mapihan; Anne-Sophie Parent; Anne-Claire Le Guillou; Ibrahim Yakoub-Agha; Sébastien Dharancy; Christian Noel; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2015-10-21       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.